Legendairy Milk Myo & D-Chiro Inositol , 120 Vegan Capsules
UPC: 810097410312
Legendairy Milk's Myo & D-Chiro Inositol is a supplement designed to support hormonal balance and ovarian function, with the manufacturer noting it may be used for PCOS support and fertility health. It provides a 40:1 ratio of Myo-Inositol to D-Chiro Inositol, which the brand states mirrors the body's normal ratio, with 2000 mg of Myo-Inositol and 50 mg of D-Chiro Inositol per serving. The D-Chiro Inositol is sourced as Caronositol®, a branded form.
This product is formulated based on clinical research referenced by the manufacturer, including studies on inositols for PCOS and hormonal support. It comes in vegan capsules made with hypromellose and carrot concentrate for color, and is also available in a chewable tablet variant for those who prefer an alternative form. The supplement is third-party tested, vegan, halal, non-GMO, and gluten-free, with manufacturing in the USA using domestic and imported ingredients.
At a glance
Supplement Facts
| Ingredient | Amount Per Serving | % Daily Value |
|---|---|---|
| Myo-Inositol | 2000 mg | * |
| D-Chiro-Inositol (Caronositol®) | 50 mg | * |
| † Daily Value not established | ||
Other Ingredients
Vegan capsule (hypromellose, carrot concentrate [color]), rice hull powder.
Made in the USA with domestic and imported ingredients.
Certifications & Claims
Label Information
Directions, warnings, and other information directly from the product label.
Suggested Use
Take 4 capsules daily. Take with food and drink to thirst.
Warning
Keep out of reach of children. Consult your healthcare provider before using if contemplating pregnancy, are pregnant, nursing, have a medical condition or use any medications. Hypersensitivity, such as allergy, may occur, in which case discontinue use. Do not use if safety seal is broken or missing. Store in a cool, dry place.
Product Info
- Brand
- Legendairy Milk
- UPC
- 810097410312
- Package Qty
- 120 count
- Dimensions
- 3.1 x 2.9 x 2.85 in
- Shipping Weight
- 0.29 lb
- First Available
- 12/2024
